Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence

L. Fedele, P. Vercellini, S. Bianchi, D. Brioschi, M. Dorta

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Twenty-four women with symptomatic multiple uterine myomas were allocated randomly to treatment with buserelin, 1200 μg/day intranasally, for 3 months followed by myomectomy (n = 8) or to immediate myomectomy (n = 16). Pre-operative treatment with buserelin reduced the mean uterine volume from 432 (SD 165) to 242 (SD 82) ml (P <0.01) but intra-operative blood loss and postoperative morbidity were not significantly less in this group. Six months after operation, pelvic examination was normal in all the patients. However, ultrasonography with transvaginal probe demonstrated the presence of myomas of <1.5 cm in five women (63%) treated pre-operatively with the analogue and in two women (13%) who underwent immediate surgery (P <0.05). Induction of a period of hypo-oestrogenism before myomectomy seems to favour short-term recurrence of uterine myomas, limiting the efficacy of surgery.

Original languageEnglish
Pages (from-to)393-396
Number of pages4
JournalBritish Journal of Obstetrics and Gynaecology
Volume97
Issue number5
Publication statusPublished - 1990

Fingerprint

Uterine Myomectomy
Myoma
Gonadotropin-Releasing Hormone
Buserelin
Recurrence
Postoperative Hemorrhage
Gynecological Examination
Ultrasonography
Therapeutics
Morbidity

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. / Fedele, L.; Vercellini, P.; Bianchi, S.; Brioschi, D.; Dorta, M.

In: British Journal of Obstetrics and Gynaecology, Vol. 97, No. 5, 1990, p. 393-396.

Research output: Contribution to journalArticle

@article{c3a0f3f25b3e4ee2ba88aa0e389e7f3c,
title = "Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence",
abstract = "Twenty-four women with symptomatic multiple uterine myomas were allocated randomly to treatment with buserelin, 1200 μg/day intranasally, for 3 months followed by myomectomy (n = 8) or to immediate myomectomy (n = 16). Pre-operative treatment with buserelin reduced the mean uterine volume from 432 (SD 165) to 242 (SD 82) ml (P <0.01) but intra-operative blood loss and postoperative morbidity were not significantly less in this group. Six months after operation, pelvic examination was normal in all the patients. However, ultrasonography with transvaginal probe demonstrated the presence of myomas of <1.5 cm in five women (63{\%}) treated pre-operatively with the analogue and in two women (13{\%}) who underwent immediate surgery (P <0.05). Induction of a period of hypo-oestrogenism before myomectomy seems to favour short-term recurrence of uterine myomas, limiting the efficacy of surgery.",
author = "L. Fedele and P. Vercellini and S. Bianchi and D. Brioschi and M. Dorta",
year = "1990",
language = "English",
volume = "97",
pages = "393--396",
journal = "British Journal of Obstetrics and Gynaecology",
issn = "0306-5456",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence

AU - Fedele, L.

AU - Vercellini, P.

AU - Bianchi, S.

AU - Brioschi, D.

AU - Dorta, M.

PY - 1990

Y1 - 1990

N2 - Twenty-four women with symptomatic multiple uterine myomas were allocated randomly to treatment with buserelin, 1200 μg/day intranasally, for 3 months followed by myomectomy (n = 8) or to immediate myomectomy (n = 16). Pre-operative treatment with buserelin reduced the mean uterine volume from 432 (SD 165) to 242 (SD 82) ml (P <0.01) but intra-operative blood loss and postoperative morbidity were not significantly less in this group. Six months after operation, pelvic examination was normal in all the patients. However, ultrasonography with transvaginal probe demonstrated the presence of myomas of <1.5 cm in five women (63%) treated pre-operatively with the analogue and in two women (13%) who underwent immediate surgery (P <0.05). Induction of a period of hypo-oestrogenism before myomectomy seems to favour short-term recurrence of uterine myomas, limiting the efficacy of surgery.

AB - Twenty-four women with symptomatic multiple uterine myomas were allocated randomly to treatment with buserelin, 1200 μg/day intranasally, for 3 months followed by myomectomy (n = 8) or to immediate myomectomy (n = 16). Pre-operative treatment with buserelin reduced the mean uterine volume from 432 (SD 165) to 242 (SD 82) ml (P <0.01) but intra-operative blood loss and postoperative morbidity were not significantly less in this group. Six months after operation, pelvic examination was normal in all the patients. However, ultrasonography with transvaginal probe demonstrated the presence of myomas of <1.5 cm in five women (63%) treated pre-operatively with the analogue and in two women (13%) who underwent immediate surgery (P <0.05). Induction of a period of hypo-oestrogenism before myomectomy seems to favour short-term recurrence of uterine myomas, limiting the efficacy of surgery.

UR - http://www.scopus.com/inward/record.url?scp=0025369232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025369232&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 393

EP - 396

JO - British Journal of Obstetrics and Gynaecology

JF - British Journal of Obstetrics and Gynaecology

SN - 0306-5456

IS - 5

ER -